Ernexa Therapeutics Inc (ERNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Operating Expenses | 5,590 | 2,095 | 1,993 | 2,501 | 2,730 |
| Operating Income | -5,590 | -2,095 | -1,993 | -2,501 | -2,730 |
| Other Income | 44 | 530 | 759 | -635 | -5,464 |
| Pre-tax Income | -5,546 | -1,565 | -1,234 | -3,136 | -8,194 |
| Income Tax | -40 | -62 | 6 | 3 | 8 |
| Net Income Continuous | -5,506 | -1,503 | -1,240 | -3,139 | -8,202 |
| Net Income | $-5,506 | $-1,503 | $-1,240 | $-3,139 | $-8,202 |
| EPS Basic Total Ops | -6.95 | 20.76 | -3.75 | -15.25 | -57.76 |
| EPS Basic Continuous Ops | -6.95 | 20.85 | -3.77 | -15.15 | -57.76 |
| EPS Diluted Total Ops | -6.95 | 20.76 | -3.75 | -15.25 | -57.76 |
| EPS Diluted Continuous Ops | -6.95 | 20.85 | -3.77 | -15.15 | -57.76 |
| EPS Diluted Before Non-Recurring Items | N/A | -0.25 | -3.75 | -15.25 | -56.22 |
| EBITDA(a) | $-3,460 | $-2,026 | $-1,923 | $-2,446 | $-2,661 |